(Q56400795)

English

Biomarkers for tuberculosis disease activity, cure, and relapse – Authors' reply

article

In more languages

edit

Statements

instance of

scholarly article

0 references

title

Biomarkers for tuberculosis disease activity, cure, and relapse – Authors' reply (English)

0 references

0 references

1 reference

Alimuddin Zumla

3

0 references

author name string

Robert S Wallis

series ordinal

1

0 references

T Mark Doherty

series ordinal

2

0 references

publication date

February 2010

0 references

published in

Lancet Infectious Diseases

0 references

volume

10

0 references

issue

2

0 references

page(s)

70-71

0 references

cites work

Biomarkers for tuberculosis disease activity, cure, and relapse

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970002-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970002-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970002-5

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S1473-3099(10)70002-5

0 references

(Q56400795)

Biomarkers for tuberculosis disease activity, cure, and relapse – Authors' reply

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)